| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 1 |
| 1 | ASPIRIN 325 MG | 1 |
| 2 | ASPIRIN 81 MG | 1 |
| 3 | CETUXIMAB | 1 |
| 4 | ENCORAFENIB | 1 |
| 5 | NAPROXEN | 1 |
| 6 | NAPROXEN SODIUM | 1 |
| 7 | NIRSEVIMAB | 1 |
| 8 | PREDNISOLONE ACETATE | 1 |
| 9 | SIROLIMUS | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NIRSEVIMAB | 1 | 0.0006 |
| 1 | ENCORAFENIB | 1 | 0.0001 |
| 2 | PREDNISOLONE ACETATE | 1 | 0.0001 |
| 3 | SIROLIMUS | 1 | 0.0001 |
| 4 | CETUXIMAB | 1 | 0.0000 |
| 5 | NAPROXEN SODIUM | 1 | 0.0000 |
| 6 | ASPIRIN | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 1 | 0.0006 |
| 1 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 2 | Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |